Filter posts

GAIN Act: A Great First Step

With over 2 million infections – and 23,000 deaths – caused by antibiotic resistant bacteria …

BIO Patient and Health Advocacy Summit: Patient-Focused Drug Development

Panelists in this morning’s opening session outlined strategies for the FDA to better engage the …

Fighting Blindness through Sound Investments in Research

Since 1971, the Foundation Fighting Blindness has raised more than half a billion dollars in …

Uniting To Accelerate Pediatric Medicine

Drug companies inherently absorb significant risk when developing compounds and biologics for clinical use. A …

New CDC Report on Alarming Rates of Antibiotic-Resistant Infections

Every year in the United States, 2 million people acquire an antibiotic-resistant infection. Of those, at …

Putting Patients First: Paving a Path to Useful CER

Comparative effectiveness research (CER) has the potential to improve health outcomes by helping people make …

FDA Consumer Update: Advances in Saving Lives with Blood

Every two seconds in the U.S., someone needs a blood transfusion or blood product—people of …

Exploring New Solutions For Neglected Diseases in Developing Countries

On Tuesday, BIO Ventures for Global Health (BVGH) announced the completion of the 30th research agreement …

CTTI: Use of Central IRBs in Multi-Center Trials to Streamline Clinical Research

Multi-center clinical trials can provide high-quality, statistically-sound evidence to answer medical questions. Earlier this year, …

New PhRMA Report: Nearly 300 Vaccines Currently in Development

Today, the Pharmaceutical Research and Manufacturers of America released a report, Medicines in Development: Vaccines …